Edwards Lifesciences (EW) Spikes on Study Results

Edwards Lifesciences Corp (NYSE: EW) shares rose 17.1% to $105.27 after the company announced over the weekend results from a clinical study involving patients at intermediate risk for open-heart surgery. Share volume was 447,000, compared to an all-day average of 422,000